A meeting of the Board of Directors of Thyrocare Technologies Limited will be held on Saturday, the 21st September 2019, to consider the report of valuation of the wholly owned subsidiary company, Nueclear Healthcare Limited (NHL), obtained from a second valuer engaged for the purpose, in the context of deciding whether to retain the Company's shareholding in NHL or dispose it of.
Shares of Thyrocare Technologies Ltd was last trading in BSE at Rs.495.25 as compared to the previous close of Rs. 474.05. The total number of shares traded during the day was 1968 in over 588 trades.
The stock hit an intraday high of Rs. 495.9 and intraday low of 471.9. The net turnover during the day was Rs. 952256.